Total Payments
$830.94
2024 Payments
$232.14
Companies
12
Transactions
23
Medicare Patients
4,323
Medicare Billing
$226,381
Payment Breakdown by Category
Other$478.93 (57.6%)
Food & Beverage$352.01 (42.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $478.93 | 2 | 57.6% |
| Food and Beverage | $352.01 | 21 | 42.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Welch Allyn | $263.41 | 1 | $0 (2021) |
| Baxter Healthcare | $253.73 | 2 | $0 (2024) |
| ABBVIE INC. | $108.10 | 7 | $0 (2024) |
| Lilly USA, LLC | $50.80 | 3 | $0 (2024) |
| Amgen Inc. | $48.39 | 3 | $0 (2024) |
| Indivior Inc. | $19.08 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $16.83 | 1 | $0 (2021) |
| Ironwood Pharmaceuticals, Inc | $15.11 | 1 | $0 (2022) |
| PFIZER INC. | $14.73 | 1 | $0 (2023) |
| Novo Nordisk Inc | $14.51 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $232.14 | 13 | ABBVIE INC. ($91.62) |
| 2023 | $31.39 | 2 | Amgen Inc. ($16.66) |
| 2022 | $287.17 | 6 | Baxter Healthcare ($215.52) |
| 2021 | $280.24 | 2 | Welch Allyn ($263.41) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $38.21 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: OUD | ||||||
| 02/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Bone Health | ||||||
| 01/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 01/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Obesity | ||||||
| 08/15/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Inflammation | ||||||
| 08/03/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/19/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Bone Health | ||||||
| 06/13/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/19/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/01/2022 | Baxter Healthcare | — | Debt forgiveness | In-kind items and services | $215.52 | General |
| 02/12/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.11 | General |
| Category: GI | ||||||
| 01/12/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/23/2021 | Welch Allyn | None (Device) | Debt forgiveness | Cash or cash equivalent | $263.41 | General |
| Category: Not Applicable | ||||||
| 03/25/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), STEGLUJAN | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 845 | 1,550 | $92,965 | $35,901 |
| 2022 | 27 | 914 | 1,843 | $113,315 | $46,563 |
| 2021 | 31 | 1,170 | 2,347 | $151,109 | $65,576 |
| 2020 | 29 | 1,394 | 2,839 | $192,673 | $78,340 |
Total Patients
4,323
Total Services
8,579
Medicare Billing
$226,381
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 182 | $41,270 | $12,151 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 103 | $15,338 | $5,238 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $8,190 | $4,126 | 50.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 58 | 139 | $3,892 | $1,824 | 46.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 66 | 158 | $2,844 | $1,635 | 57.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 158 | $1,738 | $1,327 | 76.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 31 | 45 | $2,745 | $1,305 | 47.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 45 | 119 | $2,142 | $1,133 | 52.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 62 | 115 | $1,610 | $875.15 | 54.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 41 | 41 | $2,022 | $872.07 | 43.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 25 | 25 | $875.00 | $793.00 | 90.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $925.00 | $729.25 | 78.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 22 | 43 | $1,290 | $707.78 | 54.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 41 | 41 | $1,440 | $614.59 | 42.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 41 | 124 | $896.00 | $398.04 | 44.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 11 | $853.00 | $380.82 | 44.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 22 | 43 | $688.00 | $380.12 | 55.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 16 | $1,120 | $327.45 | 29.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 16 | 16 | $656.00 | $302.72 | 46.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 19 | 19 | $622.00 | $284.81 | 45.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 22 | $814.00 | $202.50 | 24.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 29 | $725.00 | $131.18 | 18.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 25 | $150.00 | $85.25 | 56.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 12 | 12 | $120.00 | $77.01 | 64.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 204 | $45,900 | $13,430 | 29.3% |
About Patrick Watterson, PA-C
Patrick Watterson, PA-C is a Pain Medicine healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629187281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Watterson, PA-C has received a total of $830.94 in payments from pharmaceutical and medical device companies, with $232.14 received in 2024. These payments were reported across 23 transactions from 12 companies. The most common payment nature is "Debt forgiveness" ($478.93).
As a Medicare-enrolled provider, Watterson has provided services to 4,323 Medicare beneficiaries, totaling 8,579 services with total Medicare billing of $226,381. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Physician Assistant
- Location High Point, NC
- Active Since 08/29/2006
- Last Updated 12/14/2021
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1629187281
Products in Payments
- None (Device) $263.41
- VRAYLAR (Drug) $91.62
- MOUNJARO (Drug) $50.80
- Hillrom - Cardiac Ambulatory Monitor (Device) $38.21
- EVENITY (Biological) $31.73
- SUBLOCADE (Drug) $19.08
- BELSOMRA (Drug) $16.83
- Otezla (Drug) $16.66
- CREON (Drug) $16.48
- Linzess (Drug) $15.11
- PAXLOVID (Drug) $14.73
- Wegovy (Drug) $14.51
- ZENPEP (Drug) $13.13
- FARXIGA (Drug) $13.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in High Point
Hilary Brownstead, Md, MD
Pain Medicine — Payments: $42,542
Pain Medicine $42,542
Moogali Arvind, M.d, M.D
Pain Medicine — Payments: $18,244
Pain Medicine $18,244
Dr. Janus Patel, M.d, M.D
Pain Medicine — Payments: $11,541
Pain Medicine $11,541
Ms. Karla Smith, Md, MD
Pain Medicine — Payments: $11,155
Pain Medicine $11,155
Eric Moser, Md, MD
Pain Medicine — Payments: $5,030
Pain Medicine $5,030
Melissa Shelton
Pain Medicine — Payments: $4,048
Pain Medicine $4,048